(Q33893532)

29 July 2017

Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation (English)

1 reference

29 July 2017

0 references

1 reference

1 reference

1 reference

3

M Eccles

1 reference

29 July 2017

R Thomson

1

1 reference

29 July 2017

D Parkin

series ordinal

2

1 reference

29 July 2017

M Sudlow

series ordinal

4

1 reference

29 July 2017

A Robinson

series ordinal

5

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

355

1 reference

29 July 2017

956-962

1 reference

29 July 2017

9208

1 reference

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Prevalence of atrial fibrillation and eligibility for anticoagulants in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Population based study of use of anticoagulants among patients with atrial fibrillation in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

An evidence based approach to individualising treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Decision analysis in the selection, design and application of clinical and health services research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Making decisions about antithrombotic therapy in heart disease. Decision analytic and cost-effectiveness issues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Developing optimal search strategies for detecting clinically sound studies in MEDLINE.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Users' Guides to the Medical Literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

The role of decision analysis in informed consent: choosing between intuition and systematicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Measurement of health state utilities for economic appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Atrial fibrillation and mortality in an elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Canadian atrial fibrillation anticoaguiation (CAFA) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Probability of stroke: a risk profile from the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

North of England evidence based guidelines development project: methods of guideline development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Cost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Effectiveness of interventions to improve patient compliance: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

Decision aids for patients facing health treatment or screening decisions: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2990012-6

7 January 2021

10.1016/S0140-6736(00)90012-6

Identifiers

DOI

1 reference

29 July 2017

1 reference